Involvement of NK-1 and NK-2 tachykinin receptor mechanisms in jaw muscle activity reflexly evoked by inflammatory irritant application to the rat temporomandibular joint

Pain

Volumn 75, Issue 2-3, 1998, Pages 219-227

  Bakke, Merete ^a   Hu, James W ^b   Sessle, Barry J ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

CP 99,994; Masticatory muscle activity; MEN 10,376; Mustard oil; Neurokinin receptors; Temporomandibular joint

Indexed keywords

3 (2 METHOXYBENZYLAMINO) 2 PHENYLPIPERIDINE; ALLYL ISOTHIOCYANATE; NEUROKININ 1 RECEPTOR; NEUROKININ 2 RECEPTOR; NEUROKININ A [4-10][5 TYROSINE 6,8,9 DEXTRO TRYPTOPHAN 10 LYSINE]; TACHYKININ RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ELECTROMYOGRAM; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; JAW MUSCLE; MALE; MASTICATORY MUSCLE; MUSCLE CONTRACTION; NONHUMAN; PRIORITY JOURNAL; RAT; REFLEX; TEMPOROMANDIBULAR JOINT;

ANIMALS; ELECTROMYOGRAPHY; MALE; MASTICATORY MUSCLES; MUSTARD PLANT; NEUROKININ A; PEPTIDE FRAGMENTS; PIPERIDINES; PLANT EXTRACTS; PLANT OILS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NEUROKININ-1; RECEPTORS, NEUROKININ-2; REFLEX; TEMPOROMANDIBULAR JOINT;

EID: 0031922694     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(97)00223-6     Document Type: Article

References (48)

1. Bakke, M., Hu, J.W. and Sessle, B.J., Involvement of NK-1 and NK-2 receptor mechanisms in jaw muscle activity reflexly evoked by inflammatory irritant application to the rat temporomandibular joint. In: Abstracts: 8th World Congress on Pain, IASP Publications, Seattle, WA, 1996, p. 232.
2. Bakke M., Möller E. Craniomandibular disorders and masticatory muscle function. Scand. J. Dent. Res. 100:1992;32-38.
3. Chapman V., Buritova J., Honoré P., Besson J.-M. Physiological contributions of neurokinin 1 receptor activation, and interactions with NMDA receptors, to inflammatory-evoked spinal c-fos expression. J. Neurophysiol. 76:1996;1817-1827.
4. Duggan, A.W., Release of neuropeptides in the spinal cord. In: F. Nyberg, H.S. Sharma and Z. Wiesenfeld-Hallin (Eds.), Progress in Brain Research, Vol. 104, Elsevier, Amsterdam, 1995, pp. 197-233.
5. Duval P., Lenoir V., Moussaoui S., Kerdelhue B. Substance P and neurokinin A through the rat estrous cycle; comparison with ovariectomized and male rats: II. Trigeminal nucleus and cervical spinal cord. J. Neurosci. Res. 45:1996;610-616.
6. 2 receptors in mediating brief nociceptive inputs to rat dorsal horn (laminae III-V) neurons. Eur. J. Pharmacol. 242:1993;173-181.
7. Garces Y.I., Rabito S.F., Minshall R.D., Sagen J. Lack of potent antinociceptive activity by substance P antagonist CP-96,345 in the rat spinal cord. Life Sci. 52:1992;353-360.
8. Haas D.A., Nakanishi O., MacMillan R.E., Jordan R.C., Hu J.W. Development of an orofacial model of acute inflammation in the rat. Arch. Oral Biol. 37:1992;417-422.
9. Handwerker H.O., Forster C., Kirchhoff C. Discharge patterns of human C-fibers induced by itching and burning stimuli. J. Neurophysiol. 66:1991;305-315.
10. Handwerker, H.O. and Reeh, P.W., Pain and inflammation. In: M.R. Bond, J.E. Charlton and C.J. Woolf (Eds.), Proceedings of the VI World Congress on Pain, Elsevier, Amsterdam, 1991, pp. 59-70.
11. Hartwig, A.C., Law, A.S., Urban, M.O. and Gebhart, C.F., Development and use of a behavioral model of TMJ pain in the rat, Neurosci. Abstr., 22 (1996) 1814, No. 712.18.
12. Hathaway C.B., Hu J.W., Bereiter D.A. Distribution of fos-like immunoreactivity in the caudal brainstem of the rat following noxious chemical stimulation of the temporomandibular joint. J. Comp. Neurol. 356:1995;444-456.
13. Henry, J.L., Substance P and inflammatory pain: potential of substance P antagonists as analgesics. In: R.J. Bonney, N.S. Doherty, D.W. Morgan and A.F. Weldon (Eds.), Inflammatory Disease Therapy: Preclinical and Clinical Developments, Birkhäuser, Basel, 1993, pp. 75-87.
14. Holmlund A., Ekblom A., Hansson P., Lind J., Lundeberg T., Theodorsson E. Concentrations of neuropeptides substance P, neurokinin A, calcitonin gene-related peptide, neuropeptide Y and vasoactive intestinal polypeptide in synovial fluid of the human temporomandibular joint. A correlation with symptoms, signs and arthroscopic findings. Int. J. Oral. Maxillofac. Surg. 20:1991;228-231.
15. Hu J.W., Tatourian I., Vernon H. Opioid involvement in electromyographic (EMG) responses induced by injection of inflammatory irritant into deep neck tissues. Somatosens. Motor Res. 13:1996;139-146.
16. Hu, J.W., Tsai, C.-M., Bakke, M., Seo, K., Tambeli, C.H., Vernon, H., Bereiter, D.A. and Sessle, B.J., Deep craniofacial pain: involvement of trigeminal subnucleus caudalis and modulation. In: T.S. Jensen, J.A. Turner and Z. Wiesenfeld-Hallin (Eds.), Proceedings of the 8th World Congress on Pain, Progress in Pain Research and Management, IASP Press, Seattle, WA, 1997, pp. 497-506.
17. Hu J.W., Yu X.-M., Vernon H., Sessle B.J. Excitatory effects on neck and jaw muscle activity of inflammatory irritant applied to cervical paraspinal tissues. Pain. 55:1993;243-250.
18. Jessell T.M., Iversen L.L. Opiate analgesics inhibit substance P release from rat trigeminal nucleus. Nature. 268:1977;549-551.
19. Kido M.A., Kiyoshima T., Kondo T., Ayasaka N., Moroi R., Terada Y., Tanaka T. Distribution of substance P and calcitonin gene-related peptide-like immunoreactive nerve fibers in the rat temporomandibular joint. J. Dent. Res. 72:1993;592-598.
20. Luo L., Wiesenfeld-Hallin Z. The effects of pretreatment with tachykinin antagonists and galanin on the development of spinal cord hyperexcitability following sciatic nerve section in the rat. Neuropeptides. 28:1995;161-166.
21. Ma Q.-P., Woolf C.J. Involvement of neurokinin receptors in the induction but not the maintenance of mechanical allodynia in rat flexor motoneurones. J. Physiol. (London). 486.3:1995;769-777.
22. Maggi C.A., Giuliani S., Ballati L., Lecci A., Manzini S., Patacchini R., Renzetti A.R., Rovero P., Quartara L., Gaichetti A. In vivo evidence for tachykinergic transmission using a new NK-2 receptor-selective antagonist, MEN 10,376. J. Pharmacol. Exp. Ther. 257:1991;1172-1178.
23. Maggi C.A., Patacchini R., Rovero P., Giachetti A. Tachykinin receptors and tachykinin antagonists. J. Auton. Pharmacol. 13:1993;23-93.
24. McLean S., Ganong A., Seymour P.A., Snider R.M., Desai M.C., Rosen T., Bryce D.K., Longo K.P., Reynolds L.S., Robinson G., Schmidt A.W., Siok C., Heym J. Pharmacology of CP-99,994; a nonpeptide antagonist of the tachykinin neurokinin-1 receptor. J. Pharmacol. Exp. Ther. 267:1993;472-479.
25. Munro F.E., Fleetwood-Walker S.M., Parker R.M.C., Mitchell R. The effects of neurokinin receptor antagonists on mustard oil-evoked activation of rat dorsal horn neurons. Neuropeptides. 25:1993;299-305.
26. Otsuka M., Yoshioka K. Neurotransmitter functions of mammalian tachykinins. Physiol. Rev. 73:1993;229-308.
27. 2 receptors in a spinal nociceptive reflex in the rat. Eur. J. Pharmacol. 232:1993;255-261.
28. 2 receptor antagonists. Med. Res. Rev. 15:1995;139-155.
29. Radhakrishnan V., Henry J.L. Antagonism of nociceptive responses of cat spinal dorsal horn neurons in vivo by the NK-1 receptor antagonists CP-96,345 and CP-99,994, but not by CP-96,344. Neuroscience. 64:1995;943-958.
30. Regoli D., Boudon A., Fauchere J.-L. Receptors and antagonists for substance P and related peptides. Pharmacol. Rev. 46:1994;551-599.
31. Schaible H.-G., Grubb B.D. Afferent and spinal mechanisms of joint pain. Pain. 55:1993;5-54.
32. Sessle, B.J., Masticatory muscle disorders: basic science perspectives. In: B.J. Sessle, P.S. Bryant and R.A. Dionne (Eds.), Temporomandibular Disorders and Related Pain Conditions, Progress in Pain Research and Management, Vol. 4, IASP Press, Seattle, WA, 1995, pp. 47-61.
33. Sessle B.J., Hu J.W. Mechanisms of pain arising from articular tissues. Can. J. Physiol. Pharmacol. 69:1991;617-626.
34. 1 antagonist CP-99,994 on plasma extravasation in dura mater and c-fos mRNA expression in trigeminal nucleus caudalis of rats. Neuropharmacology. 34:1995;225-261.
35. Soyguder Z., Schmidt H.H., Morris R. Postnatal development of nitric oxide synthase type 1 expression in the lumbar cord of the rat: a comparison with the induction of c-fos in response to peripheral application of mustard oil. Neurosci. Lett. 180:1994;188-192.
36. Suarez-Roca H., Maixner W. Activation of kappa opioid receptors by U50488H and morphine enhances the release of substance P from rat trigeminal nucleus slices. J. Pharmacol. Exp. Ther. 264:1993;648-653.
37. 2 receptor activation to high threshold afferent fibre evoked ventral root responses in the rat spinal cord in vitro. Brain Res. 625:1993;100-108.
38. 1 neurokinin receptor activation and enhanced A- and C-fiber mediated responses in the rat spinal cord in vitro. J. Neurosci. 14:1994;3672-3687.
39. Urban L., Thompson S.W.N., Dray A. Modulation of spinal excitability: co-operation between neurokinin and excitatory amino acid neurotransmitters. Trends Neurosci. 17:1994;432-438.
40. Vedder H., Affolter H.U., Otten U. Nerve growth factor (NGF) regulates tachykinin gene expression and biosynthesis in rat sensory neurons during early postnatal development. Neuropeptides. 26:1993;351-357.
41. Woolf C.J., Thompson S.W. The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states. Pain. 44:1991;293-299.
42. Woolf C.J., Wall P.D. Relative effectiveness of C primary afferent fibers of different origins in evoking a prolonged facilitation of the flexor reflex in the rat. J. Neurosci. 6:1986;1433-1442.
43. Xu X.-J., Dalsgaard C.-J., Wiesenfeld-Hallin Z. Intrathecal CP-96,345 blocks reflex facilitation induced in rats by substance P and C-fiber-conditioning stimulation. Eur. J. Pharmacol. 216:1992;337-344.
44. Xu X.-J., Maggi C.A., Wiesenfeld-Hallin Z. On the role of NK-2 tachykinin receptors in the mediation of spinal reflex excitability in the rat. Neuroscience. 44:1991;483-490.
45. Yu X.-M., Sessle B.J., Haas D.A., Izzo A., Vernon H., Hu J.W. Involvement of NMDA receptor mechanisms in the jaw electromyographic activity and plasma extravasation induced by inflammatory irritant injection into the temporomandibular joint region. Pain. 68:1996;168-178.
46. Yu X.-M., Sessle B.J., Hu J.W. Differential effects of cutaneous and deep application of inflammatory irritant on mechanoreceptive field properties of trigeminal brain stem nociceptive neurons. J. Neurophysiol. 70:1993;1704-1707.
47. Yu X.-M., Sessle B.J., Vernon H., Hu J.W. Administration of opiate antagonist naloxone induces recurrence of increased jaw muscle activities related to inflammatory irritant application to rat temporomandibular joint region. J. Neurophysiol. 72:1994;1430-1433.
48. Yu X.-M., Sessle B.J., Vernon H., Hu J.W. Effects of inflammatory irritant application to the rat temporomandibular joint on jaw and neck muscles activity. Pain. 60:1995;143-149.